Noble

Focus: Noble specializes in auto-injector trainers and appears to be involved in early-stage vaccine and therapeutic research across infectious diseases, cardiovascular, and oncology indications. The company is headquartered in Orlando, FL with limited publicly available scale data.

Infectious Diseases Cardiovascular Oncology Vaccines

Profile data last refreshed 2d ago · AI intelligence enriched 2w ago

Open Jobs

About Noble

AI assessmentNot Hiring

No open roles listed right now. Follow Noble to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

8 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Educational Video with Male or Female Narrator

Vaccine Acceptance

N/A

Clinical Trials (1)

NCT02196454Video to Promote HPV Vaccination

N/A

Help build intelligence for Noble

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Exposure to diverse therapeutic areas including vaccines (PfSPZ Malaria), cardiovascular diagnostics, and oncology with early-stage pipeline activity
Specialized focus on auto-injector training devices positions the company in a niche medical device segment with applications across multiple indications
Early-stage portfolio with multiple Phase 1 programs offers opportunity to shape drug development strategy from inception

Watch Out For

Zero active job openings at time of analysis signals minimal hiring velocity and limited near-term career progression opportunities
Absence of financial data, employee count, funding information, and publication record raises questions about company stability, resources, and scientific credibility
Pipeline heavily skewed toward Phase 1 (5 of 7 trials) with minimal Phase 2/3 advancement—no near-term regulatory catalysts or revenue inflection points

Generated by Claude from Noble's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Determination of arterial compliance using blood pressure waveform analysis

Aortic Valve Stenosis

N/A

Clinical Trials (1)

NCT06154642Perioperative Hemodynamic and Microcirculatory Physiological Study During TAVI

N/A

PfSPZ Vaccine

Malaria

Phase 1

Clinical Trials (1)

NCT02859350Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.

Phase 1